FHIR IG analytics| Package | us.nlm.vsac |
| Resource Type | ValueSet |
| Id | ValueSet-2.16.840.1.113762.1.4.1178.2.json |
| FHIR Version | R4 |
| Source | https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1178.2/expansion |
| URL | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.2 |
| Version | 20230210 |
| Status | active |
| Date | 2023-02-10T01:02:54-05:00 |
| Name | PCSK9Inhibitors |
| Title | PCSK9 Inhibitors |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: This value set contains concepts that represent PCSK9 Inhibitors for use as cholesterol lowering agents.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Include single and multiple ingredient PCSK9 Inhibitor medications which can be prescribed. Injectable dose forms. Generic only.),(Exclusion Criteria: Exclude codes that do not meet the inclusion criteria.) |
No resources found
| CodeSystem | |
| rxnorm | RxNorm |
No narrative content found in resource
{
"resourceType": "ValueSet",
"id": "2.16.840.1.113762.1.4.1178.2",
"meta": {
"versionId": "13",
"lastUpdated": "2023-12-21T17:43:03.000-05:00",
"profile": [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension": [
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail": {
"name": "AHA Author"
}
},
{
"url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate": "2025-03-10"
},
{
"url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate": "2023-02-10"
}
],
"url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1178.2",
"identifier": [
{
"system": "urn:ietf:rfc:3986",
"value": "urn:oid:2.16.840.1.113762.1.4.1178.2"
}
],
"version": "20230210",
"name": "PCSK9Inhibitors",
"title": "PCSK9 Inhibitors",
"status": "active",
"date": "2023-02-10T01:02:54-05:00",
"publisher": "AHA Steward",
"jurisdiction": [
{
"coding": [
{
"system": "urn:iso:std:iso:3166",
"code": "US"
}
]
}
],
"purpose": "(Clinical Focus: This value set contains concepts that represent PCSK9 Inhibitors for use as cholesterol lowering agents.),(Data Element Scope: This value set may use the Quality Data Model (QDM) category related to Medication.),(Inclusion Criteria: Include single and multiple ingredient PCSK9 Inhibitor medications which can be prescribed. Injectable dose forms. Generic only.),(Exclusion Criteria: Exclude codes that do not meet the inclusion criteria.)",
"compose": {
"include": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"concept": [
{
"code": "1659156",
"display": "1 ML alirocumab 150 MG/ML Auto-Injector"
},
{
"code": "1659165",
"display": "1 ML alirocumab 150 MG/ML Prefilled Syringe"
},
{
"code": "1659177",
"display": "1 ML alirocumab 75 MG/ML Prefilled Syringe"
},
{
"code": "1659182",
"display": "1 ML alirocumab 75 MG/ML Auto-Injector"
},
{
"code": "1665895",
"display": "1 ML evolocumab 140 MG/ML Auto-Injector"
},
{
"code": "1665904",
"display": "1 ML evolocumab 140 MG/ML Prefilled Syringe"
},
{
"code": "1801319",
"display": "3.5 ML evolocumab 120 MG/ML Cartridge"
},
{
"code": "2588263",
"display": "1.5 ML inclisiran 189 MG/ML Prefilled Syringe"
}
]
}
]
},
"expansion": {
"identifier": "urn:uuid:e4d360d7-db88-4d6e-8c0b-6214af1296ad",
"timestamp": "2025-05-23T19:07:37-04:00",
"total": 8,
"contains": [
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1659156",
"display": "1 ML alirocumab 150 MG/ML Auto-Injector"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1659165",
"display": "1 ML alirocumab 150 MG/ML Prefilled Syringe"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1659177",
"display": "1 ML alirocumab 75 MG/ML Prefilled Syringe"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1659182",
"display": "1 ML alirocumab 75 MG/ML Auto-Injector"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1665895",
"display": "1 ML evolocumab 140 MG/ML Auto-Injector"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1665904",
"display": "1 ML evolocumab 140 MG/ML Prefilled Syringe"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "1801319",
"display": "3.5 ML evolocumab 120 MG/ML Cartridge"
},
{
"system": "http://www.nlm.nih.gov/research/umls/rxnorm",
"version": "05052025",
"code": "2588263",
"display": "1.5 ML inclisiran 189 MG/ML Prefilled Syringe"
}
]
}
}